Study Confirms Rapid Rise in Antipsychotic Treatment of Medicaid-Insured Children

A new study from the University of Maryland found that use of antipsychotic drugs from 1997 to 2006 increased 7- to 12-fold in a Medicaid population of about 500,000 children ages 2 to 17. The study, the latest to confirm a rapid rise of antipsychotics prescribed among Medicaid-insured children, raises questions about America’s healthcare system, says lead author Julie Zito, Ph.D., professor in the UM School of Pharmacy.
University of Maryland